Acumen Pharmaceuticals Stock Forecast

Buy candidate since Jun 22, 2026

The Acumen Pharmaceuticals, Inc. stock price gained 6.19% on the last trading day (Monday, 22nd Jun 2026), rising from $2.26 to $2.40. During the last trading day the stock fluctuated 5.46% from a day low at $2.29 to a day high of $2.42. The price has risen in 6 of the last 10 days and is up by 11.63% over the past 2 weeks. Volume fell on the last day by -125 thousand shares and in total, 572 thousand shares were bought and sold for approximately $1.37 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -11.64% during the next 3 months and, with a 90% probability hold a price between $1.66 and $2.30 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

ABOS Signals & Forecast

The Acumen Pharmaceuticals, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $2.33 and $2.39. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Friday, June 05, 2026, and so far it has risen 11.63%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not.

Support, Risk & Stop-loss for Acumen Pharmaceuticals, Inc. stock

Acumen Pharmaceuticals, Inc. finds support from accumulated volume at $2.29 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.125 between high and low, or 5.46%. For the last week the stock has had daily average volatility of 6.32%.

Our recommended stop-loss: $2.31 (-3.62%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 10 days ago.)

Trading Expectations (ABOS) For The Upcoming Trading Day Of Tuesday 23rd

For the upcoming trading day on Tuesday, 23rd we expect Acumen Pharmaceuticals, Inc. to open at $2.37, and during the day (based on 14 day Average True Range), to move between $2.33 and $2.47, which gives a possible trading interval of +/-$0.147 (+/-6.33%) up or down from last closing price. If Acumen Pharmaceuticals, Inc. takes out the full calculated possible swing range there will be an estimated 6.33% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $2.51 (4.58%) than the support at $2.29 (4.58%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Acumen Pharmaceuticals, Inc. stock A Buy?

Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Buy candidate.

Current score: 2.254 Buy Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on June 23, 2026 - $2.37 ( 1.32%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk